Explore Our Assessment Suite
Cerebral Innovations offers a suite of advanced assessments designed to meet the rigorous demands of clinical trials and research. Our assessments provide precise and reliable data, aiding in the development of therapeutic solutions for neurological and cognitive disorders. Discover how our tools can enhance your research outcomes.
Fine Motor Assessments
Our fine motor assessments provide precise measurements of motor function, crucial for evaluating the effectiveness of treatments for neurological conditions. These assessments are designed for use as endpoints in clinical trials.
Memory Assessments
Our memory assessments are tailored for conditions such as amnestic mild cognitive impairment (AMCI) and Alzheimer's disease. They aid in diagnosis, tracking disease progression, and evaluating the impact of therapeutic interventions.
Consulting Services
Our consulting team offers expert guidance to biotech and pharmaceutical companies, assisting in designing studies, selecting appropriate assessments, and optimizing clinical trial processes. We ensure your research is robust and effective.
Enhancing Clinical Trials with
Cerebral Innovations’ assessments are pivotal in clinical trials, offering precise endpoints for cognitive disorders. Our tools provide reliable, quantifiable data, crucial for evaluating treatment efficacy and disease progression in conditions like Alzheimer’s and AMCI.
Success rate in trials using our endpoints to demonstrate treatment efficacy.
0
%
Reduction in trial duration due to precise endpoint measurements.
0
+
